A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
Beijing Biotech
Parabilis Medicines, Inc.
3D Medicines
Mayo Clinic
Children's Oncology Group
Essen Biotech
Ocellaris Pharma, Inc.
Twinpig Biolab, Inc.
DualityBio Inc.
Incyte Corporation
Cancer Research UK
Shanghai Public Health Clinical Center
Kymab Limited
Sarcoma Oncology Research Center, LLC
GI Innovation, Inc.
Salubris Biotherapeutics Inc
Western Sydney Local Health District
Institut Bergonié
Incyte Corporation
Apollomics (Australia) Pty. Ltd.
Incyte Corporation
Gilead Sciences
Incyte Corporation
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Eli Lilly and Company
Shenzhen BinDeBio Ltd.
First Affiliated Hospital of Chengdu Medical College
Sun Yat-sen University